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ABSTRACT
Human Tudor-SN is involved in the degradation of
hyper-edited inosine-containing microRNA precur-
sors, thus linking the pathways of RNA interference
and editing. Tudor-SN contains four tandem repeats
of staphylococcal nuclease-like domains (SN1–SN4)
followed by a tudor and C-terminal SN domain (SN5).
Here, we showed that Tudor-SN requires tandem
repeats of SN domains for its RNA binding and
cleavage activity. The crystal structure of a 64-kD
truncated form of human Tudor-SN further shows
that the four domains, SN3, SN4, tudor and SN5,
assemble into a crescent-shaped structure. A con-
cave basic surface formed jointly by SN3 and SN4
domains is likely involved in RNA binding, where
citrate ions are bound at the putative RNase
active sites. Additional modeling studies provide a
structural basis for Tudor-SN’s preference in cleav-
ing RNA containing multiple I U wobble-paired
sequences. Collectively, these results suggest that
tandem repeats of SN domains in Tudor-SN function
as a clamp to capture RNA substrates.
INTRODUCTION
Posttranscriptional regulation, such as RNA interference,
editing and decay, plays important roles in many cellular
processes, including viral defense, chromatin remodeling,
genome rearrangement and gene expression. A number
of RNases are critically involved in these processes, such as
the RNase III enzymes Dicer and Drosha, which digest
primary double-stranded RNA transcripts to produce
siRNA and miRNA in RNA silencing (1,2). Recently,
anovelmiRNase(ribonucleaseforsmallinterferencemicro
RNA), Tudor-staphylococcal nuclease-like (SN), has been
shown to be involved in the degradation of hyper-edited
miRNA primary transcripts and intriguingly links the
pathways between RNA editing and RNA interference (3).
Tudor-SN, also called p100 orSND1, has been identiﬁed
in mammals, ﬁshes, Drosophila, Caenorhabditis elegans,
ciliates (tetrahymena) and ﬁssion yeast, but not in bacteria
(4–8). It is an ubiquitous protein with similar mRNA levels
in human pancreas, muscle, liver, lung, placenta, brain and
heart (9). Tudor-SN was ﬁrst characterized as a transcrip-
tion coactivator, interacting with several speciﬁc transcrip-
tion factors to activate their activities, including EBNA-2
(9), c-Myb (10), STAT6 (11–13) and STAT5 (14). Some of
these transcription factors regulate important cellular
signaling pathways. For example, c-Myb is involved in
hematopoietic cell growth, diﬀerentiation and apoptosis,
while STAT6 is a critical interleukin-4-induced transcrip-
tion factor in immune and antiinﬂammatory responses.
Tudor-SN was found to bridge between these speciﬁc
transcription factors and component proteins of transcrip-
tional machinery, for example, between c-Myb and Pim-1
(10), STAT6 and CBP (11), STAT6 and RNA HelicaseA
(12) and STAT6 and PC1 (13). Activation of some of these
transcription factors by Tudor-SN leads to cell prolifera-
tion and is linked to human diseases. For instance, Tudor-
SN interacting with STAT6 and PC1 activates renal
epithelial cell proliferation in autosomal-dominant poly-
cystic kidney disease (ADPKD) (13). Up-regulation of
Tudor-SN mRNA has also been observed in human colon
cancer tissues and cell lines; however, in this case,
posttranscriptional regulation of APC gene by Tudor-SN
was suggested (15).
The involvement of Tudor-SN in posttranscriptional
regulation was ﬁrst hinted by the discovery that Tudor-SN
is a component protein associated in RISC (RNA-induced
silencing complex) (7). Human Tudor-SN was then shown
to promote the cleavage of hyper-edited double-stranded
RNA containing multiple I U and U I pairs (16,17).
Subsequently, Tudor-SN was identiﬁed as a ribonuclease
speciﬁc for inosine-containing primary transcripts of
miRNA; it modulates miRNA processing and expression
through RNA editing by ADAR (adenosine deaminase
acting on RNA) (3,18). The primary transcript of human
miRNA-142 is edited by ADAR enzymes, resulting in
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transcripts are further degraded by Tudor-SN. These
results demonstrate that Tudor-SN plays an important
role in the regulation of the biogenesis and expression of
some miRNAs. Moreover, Tudor-SN interacts with U5
snRNP (small nuclear ribonucleoproteins) and functions
in spliceosome assembly and pre-mRNA splicing (19).
Therefore, this interesting protein appears to play multiple
roles in transcriptional regulation, RNA interference,
RNA editing and RNA splicing.
Sequence analyses have shown that Tudor-SN contains
four tandem repeats of SN domains (SN1 to SN4)
followed by a tudor and C-terminal partial SN domain
(SN5, see domain organization in Figure 1A) (20,21). The
SN domains share  20% sequence identity with staphy-
lococcal nuclease, which is a Ca
2+-dependent extracellular
nuclease produced by Staphylococcus aureus (22). The
tudor domain, bearing a barrel-like fold, is a protein–
protein interaction domain, usually interacting with
methylated peptides, such as the ones identiﬁed in SMN
(23), 53BP1 (24), SPF30 and TDRD (25). The crystal
structure of a C-terminal fragment of Tudor-SN (residues
654–870) containing the tudor domain and the C-terminal
SN domain (SN5) shows that a conserved aromatic cage
in the tudor domain may bind the methylated peptides of
its interaction partners in snRNPs (26). However, it
remains uncertain how Tudor-SN binds RNA and
participates in RNA interference, editing and degradation.
Here, we address the role of Tudor-SN in RNA binding
and cleavage by biochemical and X-ray crystal structure
analysis. Our results demonstrate that Tudor-SN adopts
an interesting means, using its tandem repeats of SN
domains, to capture RNA substrates.
MATERIALS AND METHODS
Cloning,expression andprotein purification
The full-length cDNA of human Tudor-SN (residues
1–885) was purchased from the Open Biosystems
(Huntsville, AL, USA) (Clone ID: 3345037). The DNA
fragments of TSN (residues 22–863), TSN-90 (residues
114–885),TSN-64(residues 315–863),TSN-SN34 (residues
315–634) and TSN-25 (residue 645–863) were ampliﬁed by
PCRandclonedintoNdeI/EcoRIsitesofexpressionvector
pET-28c (Novagen, Madison, WI, USA) to generate
N-terminal His-tagged constructs. The DNA fragments of
TSN-70 (residues 280–885) and TSN-50 (residues 476–885)
were cloned into NcoI/EcoRI sites of pET-28c to generate
the C-terminal His-tagged constructs. Primers for the TSN
fragments ampliﬁcation were listed below: TSN: F:50-
CGGGGCGCATATGCGGCAGATCAACCTCAGC-30
and R:50-GAATTCTTAGGCGCTCTTGGCTGACTCT
TG-30; TSN-90: F: 50-AGTTAACCATGGGCATGAGA
GCTAATAATCCTGAG-30 and R:50-CCGAATTCTT
GCGGCTGTAGCCAAATTCGTC-30; TSN-70: F: 50-A
GTTAACCATGGGCACCCGGGGCGCAGAAAAGC
G-30 and R: 50-CCGAATTCTTGCGGCTGTAGCCAA
ATTCGTC-30; TSN-64: F: 50-CGGGGCGCATATGGA
CAAGCAGTTTGTTGCCAAG-30 and R: 50-GAATTCT
TAGGCGCTCTTGGCTGACTCTTG-30; TSN-SN34: F:
50-CGGGGCGCATATGGACAAGCAGTTTGTTGCC
AAG-30 and R: 50-GAATTCTTAGGCCCAGACCTTC
TCTTTCTT-30; TSN-50: F: 50-GGCAT GCCATGGGC
ATCCACCGTGTTGCAGATATA-30 and R: 50-CCGA
ATTCTTGCGGCTGTAGCCAAATTCGTC-30;T S N - 2 5 :
F: 50-CGGGGCGCATATGCCAGTGCTGGAGGAG
and R: 50-GAATTCTTAGGCGCTCTTGGCTGACTCT
TG-30.
All the TSN constructs were expressed in BL21-
CodonPlus(DE3)-RIPL cells (Stratagene, La Jolla, CA,
USA) for the activity and ﬁlter-binding assays. Cells were
grown in the LB medium containing appropriate anti-
biotics to a density of  0.6 OD600 and induced using 1mM
IPTG for 20h at 208C. After the induction, cells were
harvested by centrifugation and resuspended in cold lysis
buﬀer containing 20mM Tris–HCl, pH 7.9, 500mM NaCl,
5mM imidazole, 10mM b-mercaptoethanol and EDTA-
free protease inhibitor cocktail (Roche, Mannheim,
Germany). The cells were then lyzed by microﬂuidizer
and the debris was removed by centrifugation (13000
r.p.m., 30min at 48C). The cell extracts were then loaded
onto the Ni-NTA aﬃnity column (Qiagen Inc.,
Chatsworth, CA, USA) and washed extensively with
wash buﬀer containing 20mM Tris–HCl, pH 7.9,
500mM NaCl, 40mM imidazole and 10mM b-mercap-
toethanol. The puriﬁed proteins were eluted with wash
buﬀer containing 250mM imidazole. Peak fractions were
pooled, diluted immediately into the buﬀer containing
50mM HEPES pH 7.0, 10mM EDTA, 10% glycerol and
then loaded onto the HiTrap Heparin column (Amersham
Pharmacia Biotech, Uppsala, Sweden) and eluted using the
NaCl gradient. For the TSN-50 and TSN-25, diluted
proteinwasloadedontotheHiTrapQcolumn(Pharmacia)
and also eluted using the NaCl gradient. Peak fractions
from Heparin (TSN, TSN-90, TSN-70, TSN-64, and TSN-
SN34) or Q (TSN-50, TSN-25) were concentrated and fur-
ther puriﬁed using the gel ﬁltration chromatography
column (Superdex 200, Phamacia) in the buﬀer containing
50mM HEPES, pH 7.0, 250mM NaCl, 10mM b-mercap-
toethanol and 10% glycerol. The puriﬁed protein samples
were concentrated to  10mg/ml and stored at  808C.
For crystallization experiments, TSN-64 was further
overexpressed in BL21(DE3) harboring chaperone plas-
mid pG-KJE8 (Takara Bio Inc., Shiga, Japan) or
methionine auxotrophic host B834 (Novagen). The wild-
type TSN-64 protein were expressed and puriﬁed as
described above, expect the ﬁnal gel ﬁltration buﬀer was
changed to 50mM HEPES, pH 7.0, 150mM NaCl and
10mM b-mercaptoethanol. The selenomethionine-labeled
protein Se-TSN-64 was expressed from B834 in the
minimal medium described in a previous study (27). The
puriﬁcation procedures of Se-TSN-64 were the same as
wild-type TSN-64.
Crystallization, structural determination andrefinement
Diﬀerent truncated forms of Tudor-SN were screened
for the initial crystallization conditions by the high-
throughput robotic Honeybee (960 trials) system. The
TSN-64 crystals appeared in Hampton Research Screen
Index21 in 2 months. After minor modiﬁcation, TSN-64
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in a solution containing 50mM HEPES, pH 7.0, 150mM
NaCl, 10mM b-mercaptoethanol, against a reservoir of
1.44M tri-ammonium citrate pH 7.0 by the hanging-drop
vapor diﬀusion method. Se-TSN-64 also crystallized under
the same condition using the wild-type protein crystals as
microseeds.
The Se-TSN-64 crystals were freshly soaked in the
mother liquor containing 20% glycerol prior to the data
collection at  1508C. Three multiwavelength anomalous
diﬀraction (MAD) data sets were collected by a CCD
detector at SPring-8 Taiwan beamline BL-12B2. Diﬀrac-
tion data were processed and scaled by HKL2000 (28).
Eight selenium sites were located and the initial MAD
phases of Se-TSN-64 were calculated by the CNS program
(29).TheSe-TSN-64model,builtbyCOOT(30),contained
537 residues (315–634 and 645–860) including a N-terminal
vector encoded methinonine (Met314 in the model). The
electron density maps at a loop between residues 634–645
and at the C-terminal tail (residues 861–863) were ill
deﬁned. The ﬁnal Se-TSN-64 model had an R-factor of
17.46% for 51 544 reﬂections and an Rfree of 20.93% for
5780 reﬂections, in the resolution range of 50–1.9 A ˚ . The
data collection and reﬁnement statistics are summarized
in Table 1. All ﬁgures were generated with PyMOL (31)
and the electric potential surfaces were calculated by
APBS (32).
Cleavage and filter-binding assays
The RNA oligonucleotides for RNase activity assays
were purchased from Dharmacon (Lafayette, CO, USA)
containing IIUI- or AAUA-sequence: 50-AC
UGGACAIIUICUCCGAGG-30/50-CCUCGGAGUIUU
UGUCCAGU-30 (or AAUA/UAUU in the center). The
top strands of the double-stranded RNA were 50end-
labeled with [g-
32p]ATP by the T4 PNK (NEB, Beverly,
MA, USA). The 1 pmole double-stranded RNA substrates
were then incubated with diﬀerent truncated forms of
Tudor-SN in the reaction buﬀer containing 20mM
Tris–HCl, pH 8.0, 100mM NaCl, 2mM MgCl2,1 m M
b-mercaptoethonal and 1% glycerol for 8h at 208C. After
the incubation, 1ml of Proteinase K (10mg/ml) was added
into the reaction mixture and incubated for 30min at 378C.
An equal volume of 2  TBE–urea sample buﬀers (Bio-
Rad, Richmond, CA, USA) were then added into the
reaction mixtures and heated to 708C for 2min prior to
20% denaturing polyacrylamide gel electrophoresis. After
the electrophoresis, the gels were exposed to the phosphor-
imaging plate (Fujiﬁlm) and analyzed by the imaging
system FLA-5000 (Fujiﬁlm).
For ﬁlter-binding assays, double-stranded RNA were
50-end labeled with [g-32p]ATP in both strands by T4
PNK. The labeled dsRNA (25 fmol) were then incubated
with the serial dilution of protein samples in the binding
buﬀer containing 20mM HEPES, pH 7.0, 20mM NaCl,
Table 1. Data collection and reﬁnement statistics
Data collection and MAD phasing statistics
Crystal Se-TSN-64
Beamline Spring-8 Taiwan beamline BL-12B2
Wavelength (A ˚ ) Peak
0.979389
Inﬂection
0.979545
Remote
0.964305
Resolution (A ˚ ) 1.85 1.9 1.9
Space group C2 C2 C2
Cell constants (A ˚ ) a=97.17 a=97.54 a=97.41
b=91.78 b=92.03 b=91.93
c=87.82 c=88.17 c=88.04
 =91.278  =91.258  =91.268
Total reﬂections 322497 152909 172942
Unique reﬂections 64175 60203 68052
Completeness (%) 97.9 97.9 97.8
I/s(I) – overall 20.3 14.9 15
I/s(I) – last shell 4.6 2.8 3.4
Phasing power (centrics/acentrics) 1.04/0.92
Figure of merit (centrics/acentrics) 0.67/0.45
Reﬁnement
Resolution (A ˚ ) 50–1.9
Reﬂections (working/test) 51544/5780
Rcryst/Rfree 17.46/20.93
R. M. S. bond length (A ˚ ) 0.0053
R. M. S. angles (8) 1.23
Ramachandran plot (most favored/
additional allowed/generously
allowed)
(90.2/9.4/0.4)
Number of atoms
Protein 4242
Water 690
Average B-factor (A ˚ 2)
Protein 24.08
Water 37.48
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glycerol for 30min at 48C. The reaction mixtures were
then passed through the ﬁlter-binding assay apparatus
(Bio-Dot SF microﬁltration apparatus, Bio-Rad). After
extensive washing, the protein–RNA complex-bound
nitrocellulose membrane and free RNA bound nylon
membrane were air dried and exposed to a phosphorimag-
ing plate. The intensities of protein–RNA complex and
free RNA were quantiﬁed by the program AlphaImager
IS-2200 (Alpha Innotech, San Leandro, CA, USA). The
binding percentages were calculated and normalized. The
apparent Kd values were estimated by one-site binding
curve ﬁtting using GraphPad Prism 4. The atomic
coordinates and structural factors of TSN-64 have been
deposited in the Protein Data Bank with a PDB ID of
3BDL.
RESULTS
Tandem repeats ofSN domainsare requiredfor
RNA bindingand cleavage activity
Tudor-SN has been reported to contain both DNase and
RNase activities (7). Interestingly, an amino acid sequence
comparison between SN domains of Tudor-SN and
staphylococcal nuclease showed that most of the critical
active site residues have been mutated (21). To ﬁnd out
which SN domains are involved in substrate binding and
cleavage, a number of deletion mutants of Tudor-SN were
constructed (Figure 1A). We found that the full-length
Tudor-SN was unstable and degraded into three major
stable fragments after puriﬁcation. According to the
N-terminal sequencing analysis results of these stable
degraded fragments, three truncated forms of Tudor-SN,
TSN-90 (residues 114–885), TSN-70 (residues 280–885)
and TSN-50 (residues 476–885), were constructed. Based
on the secondary structure predictions, three more con-
structs, TSN (residues 22–863), TSN-64 (residues 315–863)
andTSN-25(residues645–863)wereprepared,inwhichthe
ﬂexible loops at both the N- and C-terminal ends were
deleted. All of these His-tagged Tudor-SN truncated
proteins were then overexpressed in Escherichia coli and
puriﬁed to homogeneity by chromatographic methods,
usinga Ni-NTA aﬃnity column, followed by aheparin and
a size exclusion column. The puriﬁed proteins were
analyzed by 10% SDS–PAGE (Figure 1B) and had
>98% purity with minor degraded fragments that were
conﬁrmed by the Tudor-SN-speciﬁc antibody (data not
shown).
To test if the recombinant Tudor-SN proteins contained
DNase activity, plasmid-nicking assays were carried out.
The intensity of each substrate and product gel band was
quantiﬁedandtheestimatedsubstratecleavagepercentages
werelisted atthe bottom of thegel (Figure1C). TSN,TSN-
90 and TSN-70 had detectable DNase activity (14–3%),
whereas TSN-64 TSN-50 and TSN-25 had residual activity
(1%).Thisresult suggeststhatthe N-terminal SNdomains,
including SN1, and SN2, are required for eﬃcient DNase
activity. To test the RNase activity, 20-bp double-stranded
RNAs, containing four wobble-paired IIUI/UIUU or four
Watson–Crick base-paired AAUA/UAUU, were used
as substrates for RNA digestion experiments. We found
that TSN and TSN-90 cleaved IIUI-dsRNA with the
highest activities (5 and 15%), whereas TSN-70, TSN-64,
TSN-50 and TSN-25 had no detectable dsRNase activity
(Figure 1D). Moreover, TSN and TSN-90 cleaved
IIUI-dsRNA more eﬃciently than AAUA-dsRNA,
Figure 1. Diﬀerent constructs of Tudor-SN, and their DNase and
RNase activity assays. (A) Six constructs of Tudor-SN were prepared.
(B) The purity of Tudor-SN proteins was assayed by 10% SDS–PAGE.
(C) Plasmid digestion assays show that TSN, TSN-90 and TSN-70 had
detectable DNase activity (14% to 3%), whereas TSN-64, TSN-50 and
TSN-25 had residual activity (1%). (D) Tudor-SN truncated mutants
were incubated with 20-bp RNAs (50-end labeled on top strand)
containing the wobble base-paired IIUI/UIUU sequence or Watson–
Crick base-paired AAUA/UAUU sequence, in a reaction buﬀer for 8h
at 208C. TSN and TSN-90 cleaved IIUI-dsRNA with the highest
activities (5 and 15%), whereas TSN-70, TSN-64, TSN-50 and TSN-25
had no detectable activities (marked by -). The intensity of the cleavage
product gel band of the 10-mer RNA (marked by
 ) was quantiﬁed and
the substrate cleavage percentage was estimated, listed at the bottom of
the gel. Undetectable cleavage was marked by -.
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containingdouble-strandedRNA,consistentwithprevious
studies (3,16).
To ﬁnd out why some of the truncated mutants do not
cleave RNA eﬃciently, the dissociation constants between
Tudor-SN truncated proteins and RNAs were measured
by nitrocellulose ﬁlter-binding assays (Figure 2A and B),
in the absence of magnesium ions. The results summarized
in Figure 2E show ﬁrstly that the full-length TSN (residues
22–863) binds to IIUI- and AAUI-dsRNA with similar Kd
values in the range of  10–20nM. This result indicates
that Tudor-SN does not bind site-speciﬁcally to the IIUI
sequence, but it also binds well to Watson–Crick based-
paired RNAs. Second, the truncated proteins containing
four tandem SN (TSN), three tandem SN (TSN-90) and
two tandem SN (TSN-70 and TSN-64) domains all bound
RNA, with Kd values ranging from 20 to 700nM.
Nevertheless, the two truncated mutants, TSN-50 and
TSN-25, which did not contain tandem SN domains,
cannot bind either IIUI- or AAUA-dsRNA. These results
suggest that the N-terminal SN domains are responsible
for RNA binding and the C-terminal tudor and SN5
domains are not involved in RNA binding. To further
investigate whether the C-terminal tudor and SN5
domains are required for RNA binding, we expressed
and puriﬁed a C-terminal truncated mutant TSN-SN34
bearing only SN3 and SN4 domains. TSN-SN34 bound to
IIUI- and AAUA-dsRNA with apparent Kd values in the
range of  80–160nM, comparable to those of TSN-64.
This result conﬁrmed that the C-terminal tudor and SN5
domains are dispensable in RNA binding, and a minimum
of two tandem SN domains in Tudor-SN are required for
eﬃcient double-stranded RNA binding.
Crystalstructure of TSN-64
The diﬀerent truncated forms of Tudor-SN were screened
for crystallization conditions, and the construct of TSN-64
Figure 2. Nitrocellulose ﬁlter-binding assays between truncated Tudor-SN mutants and RNA. (A) The binding assays show that TSN, TSN-90, TSN-
70 and TSN64 all bind the 20-bp IIUI-dsRNA with comparable aﬃnity, whereas TSN-50 and TSN-25 cannot bind RNA. (B) The ﬁlter-binding
assays between Tudor-SN proteins and the 20-bp AAUA-dsRNA show that the truncated proteins containing more tandem repeats of SN domains
bind AAUA-dsRNA better. TSN-50 and TSN-25 did not bind AAUA-dsRNA. (C) SDS–PAGE analysis of puriﬁed TSN-SN34. (D) The ﬁlter
binding assays between TSN-SN34 and RNA. (E) The summary of the apparent dissociation constants (Kdapp) between Tudor-SN proteins and
20-bp IIUI- and AAUA-dsRNAs.
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crystal structure of TSN-64 was determined by MAD at
a resolution of 1.9A ˚ based on the anomalous scattering
from a Se-Met-labeled TSN-64 crystal, using diﬀraction
data collected at Taiwan beamline BL-12B2at SPring-8,
Japan. The ﬁnal structural model contained one protein
molecule (residues 315–634 and 645–860), four citrate ions
and 690 water molecules in an asymmetric unit of the C2
monoclinic cell (see diﬀraction and reﬁnement statistics in
Table 1). A long loop between SN4 and SN5 domains
(residues 635–644) was disordered without visible electron
density.
The four domains, SN3, SN4, tudor and SN5 in
TSN-64 are arranged in a distorted crescent shape. SN5
is not a partial but a complete SN domain, but a tudor
domain is inserted in SN5 and loops out to form a
separated barrel-like domain (Figure 3A and B). SN4,
though linked to SN5 in sequence, makes no contact to
SN5, but is packed against the tudor domain. The four
domains are well packed with reasonably buried interfaces
to stabilize the structure (1541.6A ˚ 2 between SN3 and
SN4, 1339.1A ˚ 2 between SN4 and tudor, and 628.9A ˚ 2
between tudor and SN5). Therefore, the four domains
should be assembled in a rigid way to maintain the
overall crescent-shaped structure. Superimposition of the
C-terminal tudor and SN5 domains in TSN-64 with the
previously reported truncated Tudor-SN structure
containing only the tudor and SN5 domains (26) (PDB
accession code: 2O4X) gave an average RMSD of 0.77A ˚
for 195Ca-atoms. This indicates that the interface
between tudor and SN5 domains is well built to ﬁx their
relative domain orientations.
The electrostatic potential mapping onto the solvent
accessible surfaces of TSN-64 was calculated and shown in
Figure 3C. The solvent accessible surfaces of SN5 domain
are highly acidic, suggesting that the SN5 domain is likely
not involved in nucleic acid interactions. On the other
hand, the surfaces of SN3 and SN4 are more basic,
especially in the concave surface of the crescent-shaped
structure. Four citrate molecules, cocrystallized with TSN-
64, are located at the basic surfaces, with two citrates
bound near the putative active site region in the SN3 and
SN4 domains, respectively. These citrate ion binding sites
provide clues for the RNA phosphate binding sites (see the
subsequent section). Based on the structural and electro-
static surface analysis results, we suggest that the nucleic
acid substrates are bound to the SN3 and SN4 domains
underneath the concave surface of the crescent-shaped
structure.
Comparison of SN domainsto staphylococcal nuclease
The three SN domains, SN3, SN4, and SN5, all bear an
OB-fold of staphylococcal nuclease, containing mainly a
Figure 3. Crystal structure of TSN-64. (A) The ribbon model of TSN-64 bound with four citrate ions. The four domains, SN3, SN4, Tudor and SN5,
are rainbow colored from blue (N-terminus) to red (C-terminus). A loop between SN4 and SN5 (residues 635–644) is disordered and is displayed as a
dotted line. (B) A schematic diagram representing the domain arrangement in TSN-64. The tudor domain is inserted in SN5 and packed between
SN4 and SN5. (C) The electrostatic potential, mapped onto the solvent-accessible surfaces of TSN-64, calculated by APBS (32). The color scale was
set from  5 kT/e (red) to +5 kT/e (blue). The molecular surfaces of tudor and SN5 are more acidic, whereas those of SN3 and SN4 are more basic.
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(Figure 4) (33). Although the overall OB-fold structures
are similar, minor diﬀerences are present in loop and
ﬂanking regions. Superimposition of respective SN
domains with staphylococcal nuclease [PDB accession
code:1EY0 (34)] shows that SN3 contains two extra long
loops (Gly355-Ile371 and Ala400-Glu412), extending out
from the side of the b-barrel; SN4 domain contains an
extra a-helix (Thr486-Gly500) ﬂanking the b-barrel and an
extra pair of antiparallel b-strands (Arg540-Glu548)
interacting with the tudor domain. SN5, on the other
hand, more closely resembles the overall structure of
staphylococcal nuclease, without the presence of extra
long loops or inserted secondary structural elements.
Interestingly, the structural-based sequence alignment
suggests that SN1 domain is more similar to SN3 with
a sequence identity of 28.1% (Figure 5A). Moreover, SN1
contains the sequences that may align with the two extra
long loops in SN3. On the other hand, the sequence of
SN2 is more similar to that of SN4 (26.9% identity),
because only SN2 bears the inserted sequences that may
align with the extra N-terminal a-helix in SN4 (from
Thr486-Gly500, marked in boxes in Figure 5B). In the
crystal structure of TSN-64, SN3 and SN4 jointly form a
structural module with a basic surface ideal for nucleic
acid binding. Taken together, these results suggest that
SN1 and SN2 likely also form a similar structural module
for nucleic acid substrate recognition. The sequence
alignment of SN1-SN2 to SN3-SN4 is shown in Figure 5B.
Two citrate ions are located at the basic surface near the
putative active sites in the SN3 and SN4 domains,
respectively. Superimposition of SN3 and SN4 separately
with the staphylococcal nuclease–pdTp complex [PDB
accession code: 2ENB (35)] shows that a citrate ion bound
in SN3 overlaps with pdTp, and a citrate ion bound in
SN4 is located right next to pdTp. This result suggests that
the citrate ions bound in TSN-64 likely mimic the
phosphate-binding sites of nucleic acid molecules.
Several residues surrounding the citrate ions, such as
Asp329, His344, Arg349, Arg352 and Arg413 in SN3, and
Ser513, Cys535, Arg537, Glu554 and Asn581 in SN4
(Figure 4D and E) are candidates for catalytic residues
involved in metal-ion binding, phosphate binding or
phosphodiester bond hydrolysis. In contrast, the residues
surrounding the corresponding putative active site in SN5
(Figure 4F) are mostly hydrophobic, such as Leu669,
Ala772, Val778, Gln777, Gln780 and Cys812, consistent
with the hypothesis that this domain may not participate
in nucleic acid binding or hydrolysis.
DISCUSSION
SNdomains inRNA bindingand cleavage
Our deletion experiments in Tudor-SN show that a min-
imum of two tandem repeats of SN domains are required
for suﬃcient RNA binding. The recombinant Tudor-SN
proteins indeed prefer to cleave a 20-bp I U-containing
RNA over an A U-containing RNA. The crystal structure
Figure 4. Structural comparison between staphylococcal nuclease (SMN) and SN domains in TSN-64. (A) Superposition of staphylococcal nuclease
(PDB entry: 1EY0 (34)) and SN3 domain. SN3 contains extra long loops, marked by red dashed circles. (B) Superposition of SMN and SN4. SN4
contains an extra pair of b-strands and an a-helix, delineated by the blue circles. (C) Superposition of SMN and SN5. (D) The stereo view of the
putative active site of SN3. A citrate ion (labeled as CIT) bound at the active site, overlapped with the pdTp bound at the active site of SMN [PDB
accession code: 2ENB (35)]. (E) The stereo view of the putative active site of SN4. A citrate ion is bound next to the pdTp bound in SMN. (F) The
putative active site in SN5. Most residues are hydrophobic, not appropriate for metal-ion binding or RNA hydrolysis.
Nucleic Acids Research, 2008, Vol. 36, No. 11 3585of TSN-64 further shows that SN3 and SN4 domains form
a compact structural module and jointly generate a basic
surface suitable for RNA recognition. The question is how
these two SN domains work together to recognize
a double-stranded RNA.
We noticed that the two SN domains in TSN-64 are
related to each other by a pseudo 2-fold symmetry
(Figure 6B). This 2-fold symmetry might be linked to
the protein function of RNA recognition since the two
sugar-phosphate backbones of a double-helical RNA
are also related approximately by a 2-fold symmetry.
Therefore, the structural module of SN3–SN4 seems ideal
for the interactions with a double-stranded RNA. We thus
built a complex model by superimposition of the dyad axis
between SN3 and SN4 in TSN-64 to the dyad axis in a
16-bp RNA [PDB accession code: 1DI2 (36)]. In this way,
one of the rotational axes of the RNA molecule in the
complex was ﬁxed by the superposition. Another rota-
tional axis was further constrained by the shape of the
cleft, which allows the RNA helix to pass through in only
one direction. The ﬁnal model, displayed in Figure 6A, has
a double-stranded RNA snugly bound at the concave side
of the crescent-shaped structure, with one strand of
phosphate backbone interacting mainly with one SN
domain. It is possible that the SN1 and SN2 domains
assemble together with SN3 and SN4 to create another
concave surface for RNA binding.
This model of Tudor-SN–RNA complex is consistent
with our biochemical and structural data, except that the
phosphate backbones are far away from the putative
active sites in SN3 and SN4 domains (marked as stars
in Figure 6B). Previous biochemical studies showed that
Tudor-SN eﬃciently cleave only the dsRNAs containing
multiple I U and U I wobble base pairs, but not the RNAs
containing the isosteric G U and U G wobble base pairs
or Watson–Crick A U base pairs (3,16,17,37). It has been
shown that the RNA containing tandem I U pairs are
signiﬁcantly less stable than the ones containing G U
or A U base pairs; the melting points of an 8-bp RNA
containing two or three tandem I U base pairs are >208C
lower than those of G Uo rA  U base-paired RNAs (38).
Therefore, the dsRNA containing multiple I U pairs
might have a speciﬁc structure that is less stable and
deviates considerably from a classical A-form structure.
Figure 5. Sequence comparison of SN domains and structural-based sequence alignment between SMN and SN domains in Tudor-SN. (A) The
sequence identities between diﬀerent SN domains in Tudor-SN show that SN1 shares the highest sequence identity with SN3 (28.1%), while SN2
shares the highest sequence identity with SN4 (26.9%). (B) Sequence alignment between SMN and Tudor-SN. The secondary structures of SMN and
TSN-64 are displayed at the top and bottom of the sequences, respectively. As SN1 shares higher sequence identity with SN3, and SN2 shares higher
sequence identity with SN4, SN1-SN2 domains are aligned with SN3–SN4.
3586 Nucleic Acids Research, 2008, Vol. 36, No. 11It is likely that the I U-containing RNA bound at Tudor-
SN has a distorted open conformation so that the RNA
backbones are displaced from a well-annealed structure
and thus are bound at the active sites (schematic diagram
in Figure 6C). Only the hyper-edited double-stranded
RNA may adopt this speciﬁc conformation and therefore
only the RNA substrates containing multiple I U and U I
pairs can be cleaved eﬃciently by Tudor-SN. This explains
previous observations showing that the in vitro-edited pri-
miRNA-142 can be degraded sensitively by Tudor-SN in
proportion to the number of A!I modiﬁcations (3).
Moreover, our hypothesis that two SN domains form
a structural module for dsRNA binding is further
supported by sequence data showing that Tudor-SN
from various species contains even numbers of tandem
repeats of SN domains, that is, either four for human,
mouse, ﬁsh, drosophila, C. elegans and ﬁssion yeast or two
for tetrahymena.
Biological roles of Tudor-SNand its substrates
Our biochemical and structural data support the previous
ﬁnding that Tudor-SN functions as a miRNase (RNase
for microRNA), which is more speciﬁc for I U-containing
double-stranded RNA. To date, the ADAR deaminase-
edited primary transcript of miRNA-142 is the only
identiﬁed natural substrate for Tudor-SN (3). Mature
miRNA-142 expression levels increased substantially in
ADAR1 null or ADAR2 null mice since Drosha processed
only the unedited primary miRNA transcripts but not the
hyper-edited ones. Tudor-SN plays an opposite role in
that it degrades the hyper-edited miRNA more eﬃciently
than the unedited ones. Over the decades, considerable
lines of evidence have accumulated showing that miRNAs
play key roles in the regulation of gene expression and
aﬀect mRNA degradation and translation (39). Therefore,
besides functioning as a transcription coactivator and
regulating gene expression at the transcriptional level,
Tudor-SN may likely degrade negative regulators of
hyper-edited miRNA and thus upregulate gene expression
at the posttranscriptional level.
Apart from hyper-edited primary transcripts of
miRNA, are there other RNA types that may be good
candidate substrates for Tudor-SN? Firstly, bioinfor-
matics screening for A!I RNA editing sites based on
the comparison of cDNA or EST sequences with the
corresponding genome sequences predicted that >85% of
pre-mRNAs are edited, with the majority in introns
( 90%) and UTRs containing Alu repeats or LINE
repeats in human transcriptome (40–43). These A!I
edited pre-mRNAs, containing inverted repeats that fold
into double-stranded RNA, are candidate substrates for
Tudor-SN, which in turn, may control gene expression of
mRNAs bearing repeat sequences (44). Second, the
cytoplasmic ADAR1 is induced by interferon (45),
implying that this enzyme is involved in antiviral defense.
Combined with the ﬁnding demonstrating that a number
of viral RNAs are hyper-edited, Tudor-SN might target
these hyper-edited viral RNAs and work together with
ADAR1 to combat viral infections (17). Third, up- or
down-regulation of a number of miRNA levels has been
shown to play a role in antiviral defense during viral
infection not only in plants and invertebrates (46), but
also in mammals, through the interferon system (47).
Therefore, it will be intriguing to ﬁnd out whether Tudor-
SN is involved in the regulation of these host miRNA
levels. As there is no direct evidence for the role of Tudor-
SN in the degradation of hyper-edited pre-mRNA, viral
RNA or host miRNA, more studies are needed to further
reveal Tudor-SN’s natural substrates.
Figure 6. Structural model of TSN-64 bound with a double-stranded RNA. (A) Two diﬀerent views of the model show that a dsRNA may bind
snugly at the concave basic surface in TSN-64 to SN3 and SN4 domains. (B) A pseudo 2-fold symmetry axis is identiﬁed between SN3 and SN4
domains. The structural model was built by aligning the dyad axis between a 16-bp RNA [PDB accession code: 1DI2 (36)] to the dyad axis between
SN3 and SN4. Two stars mark the likely location of putative active sites in SN3 and SN4, based on the pdTp-binding site in staphylococcal nuclease.
(C) The part of double-stranded RNA containing mis-paired I Uo rU  I sequences may have an open conformation. The phosphate backbones may
displace from a canonical A-form conformation so that they can be bound near the active sites in the SN3 and SN4 domains.
Nucleic Acids Research, 2008, Vol. 36, No. 11 3587How Tudor-SN’s RNase activity is regulated is another
important issue that has not yet been addressed. Tudor-
SN is an ubiquitous protein present in the nucleus (4,9),
cytoplasm (5,16), or both (7). It has been shown that
a recombinant Tudor-SN, supplemented with a limited
amount of Xenopus laevis oocyte extract, cleaved a IIUI-
containing dsRNA much more eﬃciently than the
unsupplemented one (16), indicating that some other
factors may be involved in promoting its RNase activity.
The recombinant Tudor-SN puriﬁed from yeast enhanced
the cleavage of IIUI-dsRNA (20-mer) but no RNase
activity was detected when the RNA substrates were
incubated with 5mM Tudor-SN alone (37). In contrast,
the recombinant ﬂag tagged Tudor-SN from HeLa cell
digested inosine hyper-edited miRNA eﬃciently (3). In
this study, the recombinant Tudor-SNs were puriﬁed from
E. coli, and they had weak DNase and RNase activities. It
is likely that Tudor-SN needs other cofactors to enhance
its nuclease activity, or Tudor-SN prefers to digest a
longer native hyper-edited substrate. The tudor domain in
Tudor-SN is known to be a protein–protein interaction
domain and it could interact with other cofactors for the
regulation of Tudor-SN’s activities. The SN5 domain,
appearing not to be involved in nucleic acid interactions,
may also be a good candidate for the screening of protein–
protein interaction partners. Our structure analysis thus
paves the way for future functional analyses of this
versatile protein in RNA editing, interference and splicing.
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